105 related articles for article (PubMed ID: 20703937)
21. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
[TBL] [Abstract][Full Text] [Related]
22. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
23. Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
Woo SU; Park KH; Woo OH; Yang DS; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Breast Cancer Res Treat; 2010 Nov; 124(2):481-5. PubMed ID: 20361250
[TBL] [Abstract][Full Text] [Related]
24. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
[TBL] [Abstract][Full Text] [Related]
25. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
[TBL] [Abstract][Full Text] [Related]
26. Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism.
He Y; Liu H; Chen Q; Shao Y; Luo S
Mol Genet Genomic Med; 2019 Sep; 7(9):e871. PubMed ID: 31317673
[TBL] [Abstract][Full Text] [Related]
27. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
28. TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness.
Shan J; Dsouza SP; Bakhru S; Al-Azwani EK; Ascierto ML; Sastry KS; Bedri S; Kizhakayil D; Aigha II; Malek J; Al-Bozom I; Gehani S; Furtado S; Mathiowitz E; Wang E; Marincola FM; Chouchane L
Cancer Res; 2013 May; 73(9):2840-9. PubMed ID: 23447579
[TBL] [Abstract][Full Text] [Related]
29. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
30. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
[TBL] [Abstract][Full Text] [Related]
31. Association between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.
Zhang X; Jin G; Li J; Zhang L
Med Sci Monit; 2015 Apr; 21():1115-23. PubMed ID: 25890491
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
33. Involvement of microRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia.
Mir R; Al Balawi IA; Duhier FMA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2581-2589. PubMed ID: 30256064
[TBL] [Abstract][Full Text] [Related]
34. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
35. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
Ding DP; He XF; Zhang Y
Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
[TBL] [Abstract][Full Text] [Related]
36. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
[TBL] [Abstract][Full Text] [Related]
37. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
[TBL] [Abstract][Full Text] [Related]
38. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: a pooled analysis of 83 studies with 74,019 participants.
Zhang Y; Jia H; Wang S; Jiang D
Minerva Med; 2017 Feb; 108(1):57-73. PubMed ID: 27824246
[TBL] [Abstract][Full Text] [Related]
39. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
40. Reserch of the gene polymorphism TOX3 / LOC643714 and the risk of breast cancer development in persons exposed to ionizing radiation after Chornobyl disaster.
Polinyk SI; Rybchenko LA; Klimyk BT
Probl Radiac Med Radiobiol; 2017 Dec; 22():450-462. PubMed ID: 29286526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
